Clinical Trials Logo

Filter by:
NCT ID: NCT04064476 Enrolling by invitation - Schizophrenia Clinical Trials

The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Start date: August 18, 2019
Phase:
Study type: Observational

This is a 49 weeks prospective, non-interventional cohort study. To observe the effect of long-acting injection antipsychotic(LAI), paliperidone palmitate on prevention of recurrence and symptom control in schizophrenia patients with violence risk. This study can be extended according to the implementation of the project and extended follow-up time.

NCT ID: NCT04061837 Enrolling by invitation - Clinical trials for Mitral Regurgitation

MitralStitch Mitral Valve Repair System for Mitral Regurgitation

Start date: August 23, 2019
Phase: N/A
Study type: Interventional

The main objective is to assess the effectiveness and safety of the MitralStitch repair system in patients with moderate to severe and severe mitral regurgitation.

NCT ID: NCT04029350 Enrolling by invitation - Clinical trials for Non Small Cell Lung Cancer

Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M

ALTN-03
Start date: July 31, 2019
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy and safety of Anlotinib combined with Icotinib as the second-line treatment in stage IIIb-IV NSCLC patients with sensitive EGFR and T790M mutations.

NCT ID: NCT04028544 Enrolling by invitation - Heart Failure Clinical Trials

The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients

Start date: March 26, 2019
Phase: Phase 4
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled study including patients with ejection fraction decreased heart failure under standardized treatment, to evaluate QiShenYiQi (QSYQ) dropping pill's curative effect in reducing cardiovascular death and heart failure rehospitalization compared with placebo.

NCT ID: NCT04024553 Enrolling by invitation - Bipolar Disorder Clinical Trials

A Genetic Family Cohort Study of Bipolar Disorder in Chinese Han Population

Start date: March 28, 2019
Phase:
Study type: Observational

This study intends to find out the pathogenic genes of bipolar disorder by collecting the two-phase family of Chinese Han population with the large sample using a family cohort study design, combined with the new generation of high-throughput sequencing technology and Genome-Wide Association Studies (GWAS), Proteomics, bioinformatics analysis, etc., which is expected to be clarified at the genetic level. The pathogenesis of bipolar disorder. At the same time, the investigators will conduct a five-year follow-up of cognitive function, brain function imaging and other major clinical symptoms in patients with bipolar disorder in the core family, and to explore familial bipolar disorder and sporadic biphasic. Differences in the clinical features of the disorder, in order to explore sensitive and specific biomarkers from a multidimensional perspective (cognitive function, brain imaging, genetic features, clinical features, etc.), which may contribute to bipolar disorder in the future. Accurate diagnosis and early identification and prevention have important scientific significance and clinical diagnosis and treatment significance.

NCT ID: NCT04010006 Enrolling by invitation - Stomach Neoplasms Clinical Trials

Trials Comparing of HD Versus 4K Laparoscopy for Gastric Cancer

Start date: July 15, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the feasibility of 4K Laparoscopic Surgery for Gastric Cancer.

NCT ID: NCT03995342 Enrolling by invitation - Frailty Syndrome Clinical Trials

The Correlation and Intervention of Intestinal Flora and Frailty in the Elderly

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The study aim to evaluate the improvement and correlation of soluble dietary fiber (prebiotics) in the frailty of elderly people by a randomized, double-blind, placebo-controlled clinical trial.

NCT ID: NCT03949101 Enrolling by invitation - Myopia Clinical Trials

Atropine for Children and Adolescent Myopia Progression Study

Start date: May 8, 2019
Phase: Phase 4
Study type: Interventional

Investigators are going to conduct a randomized controlled trial that myopic children are randomly allocated into two groups: combined use of 1% atropine and 0.01% atropine (experimental group) and 0.01% atropine (control group) in order to explore a better way to control myopia progression and eliminate adverse effects at the same time, provide reliably evidence for clinical guideline of atropine use in children, and investigate the mechanism of atropine on eyes.

NCT ID: NCT03948269 Enrolling by invitation - Menopausal Syndrome Clinical Trials

The Effect of Internet- and Mobile-based Group Treatment in Menopausal Women

IMGTMP
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Background: Menopause syndrome generally occurs with and is related to psychological problems. However, Internet- and mobile-based group treatment (imGT) may improve women's physiological and psychological conditions. Objective: To investigate the efficacy of group treatment with or without Internet- and mobile-based treatment of menopause, mood swings and quality of life status. Methods: This protocol is for a randomized controlled clinical trial with a sample of 144 menopausal women divided into 2 groups: imGT and face-to-face group treatment (ffGT). The primary outcome will be the menopausal symptom improvement of the two groups, as assessed by Greene Climacteric Scale. The secondary outcomes will be quality of life, assessed by the Short Form 36 Health Survey Questionnaire; insomnia, assessed by the Pittsburgh Sleep Quality Inventory; anxiety, assessed by the Hamilton Anxiety Rating Scale; and therapeutic alliance, assessed by the Working Alliance Inventory-Short Revised. imGT will be performed once a week for 1.5 hours for 10 weeks with a daily Punched-in on the WeChat App; ffGT will be performed once a week for 1.5 hours for 10 weeks. All outcomes will be assessed at baseline, at a post-intervention evaluation (week 10), and at a follow-up evaluation (week 22). Discussion: This study will be the first clinical trial to examine the effects of imGT on menopausal women in China. If imGT is found to be equivalent to or superior to ffGT, it will facilitate easier access to menopausal health services, which may be feasible to offer to other medical institution.

NCT ID: NCT03930082 Enrolling by invitation - Clinical trials for Frail Elderly Syndrome

Frailty Assessment of Patients With Gastrointestinal Surgery

Start date: January 1, 2019
Phase:
Study type: Observational

Patients aged 65 or older under gastrointestinal surgery will be enrolled,the investigators will assess the frailty of these patients by Frailty Index Scale and explore the correlation between the frailty and perioperative adverse events.